Product description
MUCONIS nasal spray facilitates the fluidification and mechanical removal of mucus and/or mucopurulent secretions stagnant inside the nasal cavity and inside the paranasal sinuses. It acts by fluidifying the mucus through the physical/mechanical action of its components and is indicated in: Fluidification of airways secretions; Decongests mucosa; Supports mucociliary clearance; and improves the symptoms and the course of acute, subacute and chronic inflammation of the upper respiratory track. 
 
Indications
 
MUCONIS is indicated in upper respiratory tract diseases, including:
Sinusitis
Rhinosinusitis
Rhino-bronchial syndrome
 
Unique Selling Points (USP’s)
Supported by clinical studies
Indicated from 2 years old
Adjuvant to corticosteroid therapies
Patient compliance